Dr Jeffrey A Wachs, DO | |
2163 Pray Meadow Road, Glenbrook, NV 89413 | |
(775) 843-1754 | |
(775) 749-5021 |
Full Name | Dr Jeffrey A Wachs |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 2163 Pray Meadow Road, Glenbrook, Nevada |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972543676 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 20A5556 (California) | Secondary |
207Q00000X | Family Medicine | DO630 (Nevada) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jeffrey A Wachs, DO Po Box 110, Glenbrook, NV 89413-0110 Ph: (775) 843-1754 | Dr Jeffrey A Wachs, DO 2163 Pray Meadow Road, Glenbrook, NV 89413 Ph: (775) 843-1754 |
News Archive
Alzheimer´s disease (AD) is the most common disease underlying memory problems and dementia in the elderly. One of the invariable pathologies in AD is degeneration of cholinergic synapses in brain cortex and hippocampus.
The American Chiropractic Association, in response to recent research calling into question the efficacy of acetaminophen in the management of spinal pain, strongly encourages patients and healthcare providers to consider the benefits of a conservative approach to back pain.
Current drug development for neuropsychiatric disorders is in crisis, say experts. More than 90 percent of all drugs that are developed for illnesses like schizophrenia, depression, Alzheimer's disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between the two species.
The U.S. Army Research Laboratory's Army Research Office recently awarded a New York University Polytechnic School of Engineering researcher a grant to advance protein-engineered, environmentally responsive hydrogels that could replicate biochemical processes currently found only in nature. These protein hydrogels could become fundamental building blocks of important new biomimetic materials.
SCIENTISTS seeking to make chemotherapies which are less harmful to cancer patients have reported "highly promising" results from a synthetic molecule called TPP.
› Verified 3 days ago